Bladder Cancer With FGFR3 Mutation or Fusion

Explore clinical trials studying Bladder Cancer With FGFR3 Mutation or Fusion. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Bladder Cancer With FGFR3 Mutation or Fusion trial results

Completed

NCT01004224

Conditions: Advanced Solid Tumors With Alterations of FGFR1, 2 and or 3, Advanced Solid Tumors With FGFR1 Amplication, Advanced Solid Tumors With FGFR2 Amplication, +19 more
Locations: Novartis Investigative Site Duarte, California, United States

Novartis Investigative Site Los Angeles, California, United States

Novartis Investigative Site Los Angeles, California, United States

University of Colorado Dept. of Anschutz Cancer (3) Aurora, Colorado, United States

View all 50 locations